Uwe Totzke

Holding University degrees in Biology (PhD) and Pharmaceutical Medicine, Uwe has a thorough knowledge of clinical trial designs, statistics, and overall drug development, as well as a strong scientific background in therapeutic areas. During more than 10 years in drug development and life cycle management and as an advanced medical writer certified by the European Medical Writing Association (EMWA), he has come across and gathered hands-on experience with almost any kind of regulatory document. Simultaneously, he has kept in touch with basic science and clinical research through engagement in investigator-initiated trials and academic research projects leading to several peer reviewed journal publications. From his personality, Uwe is highly flexible, self-motivated, persistent, and focused (high-performance marathon runner and among the German all-time top 20 ultra marathon runners).

Don Dreher

Trained in Internal Medicine (MD, FMH Respiratory Medicine), Molecular Biology (PhD), and Pharmaceutical Medicine (ECPM), Don has worked for many years in the Pharmaceutical Industry as Clinical Group Head and Senior Medical Director (Merck Serono), Senior Manager Clinical Research (Novartis), and Project Manager (HPM Geneva SA). He has conceived and led early to late stage Clinical Development Plans, numerous protocols/reports for international phase I-IV trials, and the clinical sections of successful US/EU New Drug Applications. Don has delivered stationary and ambulatory patient care as Resident and Senior Physician (Geneva University Hospital). Before joining pharmaceutical projects, he has also led an internationally funded scientific research group in immunology and infectious disease (University of Geneva). Having served in a small CRO and in multinational Pharma, Don has learned to meet the client’s needs from either side. He can see the larger business picture and understands the critical importance of clinical and regulatory details.